Concepedia

Jeffery S. Russell

JS

Statistics

Publications

46

Citations

5K

H-Index

32

Active since

1998

Affiliations

Moffitt Cancer Center(Current)

National Cancer Institute

Memorial Sloan Kettering Cancer Center

University of Colorado Denver

Tennessee Oncology

Jeffery S. Russell is an author at Moffitt Cancer Center specializing in medicine, oncology, and radiation therapy.

ORCID

Publications per year

1998–2024

46

Publications

46

Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial

Howard L. Kaufman, Jeffery S. Russell, Omid Hamid et al. · The Lancet Oncology · 2016 · 1.2K citations · Full text

, , +11

Talquetamab, a T-Cell–Redirecting GPRC5D Bispecific Antibody for Multiple Myeloma

Ajai Chari, Monique C. Minnema, Jesús G. Berdeja et al. · New England Journal of Medicine · 2022 · 649 citations · Full text

, , +17

Efficacy and Safety of First-line Avelumab Treatment in Patients With Stage IV Metastatic Merkel Cell Carcinoma

Sandra P. D’Angelo, Jeffery S. Russell, Célèste Lebbé et al. · JAMA Oncology · 2018 · 368 citations · Full text

, , +17

Updated efficacy of avelumab in patients with previously treated metastatic Merkel cell carcinoma after ≥1 year of follow-up: JAVELIN Merkel 200, a phase 2 clinical trial

Howard L. Kaufman, Jeffery S. Russell, Omid Hamid et al. · Journal for ImmunoTherapy of Cancer · 2018 · 330 citations · Full text

, , +17

The Genomic Landscape of Merkel Cell Carcinoma and Clinicogenomic Biomarkers of Response to Immune Checkpoint Inhibitor Therapy

Todd C. Knepper, Meagan Montesion, Jeffery S. Russell et al. · Clinical Cancer Research · 2019 · 170 citations

, , +17

1–5 of 46